NCT07606066ClinicalTrials.gov
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
En bref
The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient…
Observationnelle2 150 participants recherchés76 sites7 pays
Catégories
Enregistré dans 1 registre
- ClinicalTrials.govNCT07606066Ouvrir cette fiche sur ClinicalTrials.govSynchronisé il y a 4 semaines
Une même étude peut être enregistrée dans plusieurs registres. Nous l'affichons une seule fois et renvoyons vers chaque fiche que nous détenons.
Les informations de l'essai sont affichées telles que publiées par le registre, dans leur langue d'origine.
Cette étude vous intéresse ?
Se connecter ou créez un compte pour manifester votre intérêt et suivre cette étude.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Not stated: Registered after enrolment began (about 20 days after the recorded start)First posted 2026-05-26; recorded start 2026-05-06
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Not stated: Whether participants are randomly assigned is not stated in the registry recordNo allocation method is recorded
- Not stated: A comparison group is not stated in the registry recordThe record describes a single study arm
- Not stated: Whether the study is blinded is not stated in the registry recordNo masking information is recorded
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 1019 other studies in this databaseCounted from the lead sponsor named in the record (AstraZeneca)
- Present: Sponsor has posted results for at least one studyBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation0/20
Allocation not stated in the record
- Blinding0/20
Masking not stated in the record
- Control arm0/15
No comparator arm stated in the record
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre8/8
Multi-centre: 71 sites
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A large study, international in scope: 2,150 participants (target), run at 76 sites, across 7 countries.
How this score is built
- Enrolment33/40
2,150 participants (target)
- Site count21/25
71 sites
- Country count12/15
7 countries
- Planned duration5/10
Planned over about 11 months
- Sponsor scale10/10
AstraZeneca has led 991 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
Résumé
The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions.
Affections
- Type 2 Diabetes
Éligibilité
| Sexe | Tous |
|---|---|
| Âges | 18 Years – Aucun maximum |
| Volontaires sains | Non |
| Méthode d'échantillonnage | NON_PROBABILITY_SAMPLE |
Population de l'étude
Adults with Type 2 Diabetes
Éligibilité telle qu'elle figure dans le registre
Éligibilité en énoncés simples
Les critères de cette fiche n'ont pas encore été décomposés en énoncés distincts. Le texte du registre ci-dessus est complet et fait foi.
Conception de l'étude
| Type d'étude | Observationnelle |
|---|---|
| Phase | Non précisé dans la fiche du registre |
| Répartition | Non précisé dans la fiche du registre |
| Modèle d'intervention | Non précisé dans la fiche du registre |
| Objectif principal | Non précisé dans la fiche du registre |
| Insu | Non précisé dans la fiche du registre |
| Recrutement | 2 150 participants recherchés |
Promoteur et collaborateurs
- AstraZeneca Promoteur
Groupes et interventions
- Participants with Type 2 Diabetes
Participants with Type 2 Diabetes
Interventions
- Autre Procedure: assessment
The approximate volume of blood required is 2 mL
Critères de jugement
Critère de jugement principal
Patient demographics
Summary statistics
Délai Visit 1 (Single day)
Critère de jugement principal
Medical and surgical history
Summary statistics
Délai Visit 1 (Single day)
Critère de jugement principal
Concomitant medication
Summary statistics
Délai Visit 1 (Single day)
Critère de jugement principal
HbA1c levels
Summary statistics
Délai Visit 1 (Single day)
Critère de jugement secondaire
Referral to ongoing or future T2DM study.
Number of participants with high likelihood of meeting eligibility criteria in ongoing or future T2DM studies, for referral to those studies.
Délai Visit 1 (Single day)
Dates
| Date de début | 6 mai 2026 (réelle) |
|---|---|
| Achèvement principal | 31 mars 2027 (estimée) |
| Achèvement | 31 mars 2027 (estimée) |
| Première publication | 26 mai 2026 (réelle) |
| Dernière mise à jour | 25 août 2026 |
| Résultats publiés | Non précisé dans la fiche du registre |
| Statut vérifié pour la dernière fois | mars 2026 |
Réelle signifie que l'événement a eu lieu. Estimée signifie que le promoteur s'y attend. Les deux ont un sens différent.
Lieux
19 sites sont en recrutement
Brazil
| Établissement | Ville | État ou région | Statut |
|---|---|---|---|
| Research Site | Barretos | Pas encore en recrutement | |
| Research Site | Brasília | Pas encore en recrutement | |
| Research Site | Campinas | São Paulo | Pas encore en recrutement |
| Research Site | Curitiba | Paraná | En recrutement |
| Research Site | Fortaleza | Ceará | Pas encore en recrutement |
| Research Site | Natal | Rio Grande do Norte | Pas encore en recrutement |
| Research Site | Porto Alegre | Rio Grande do Sul | Pas encore en recrutement |
| Research Site | Rio de Janeiro | Pas encore en recrutement | |
| Research Site | São José dos Campos | São Paulo | Pas encore en recrutement |
| Research Site | São Paulo | São Paulo | Pas encore en recrutement |
| Research Site | São Paulo | São Paulo | Pas encore en recrutement |
Hungary
| Établissement | Ville | État ou région | Statut |
|---|---|---|---|
| Research Site | Budapest | En recrutement | |
| Research Site | Budapest | Pas encore en recrutement | |
| Research Site | Budapest | En recrutement | |
| Research Site | Budapest | HU | En recrutement |
| Research Site | Budapest | HU | En recrutement |
| Research Site | Debrecen | HU | Pas encore en recrutement |
| Research Site | Salgótarján | Pas encore en recrutement | |
| Research Site | Szeged | HU | Pas encore en recrutement |
| Research Site | Szolnok | Pas encore en recrutement | |
| Research Site | Zalaegerszeg | En recrutement |
India
| Établissement | Ville | État ou région | Statut |
|---|---|---|---|
| Research Site | Bangalore | Karnataka | Pas encore en recrutement |
| Research Site | Belagavi | Karnataka | Pas encore en recrutement |
| Research Site | Belagavi | Karnataka | Pas encore en recrutement |
| Research Site | Calicut | Kerala | Pas encore en recrutement |
| Research Site | Chennai | Tamil Nadu | Pas encore en recrutement |
| Research Site | Coimbatore | Tamil Nadu | Pas encore en recrutement |
| Research Site | Delhi | New Delhi | Pas encore en recrutement |
| Research Site | Guntur | Andhra Pradesh | Pas encore en recrutement |
| Research Site | Guwahati | Assam | Pas encore en recrutement |
| Research Site | Indore | Madhya Pradesh | Pas encore en recrutement |
| Research Site | Jaipur | Rajasthan | Pas encore en recrutement |
| Research Site | Kochi | Kerala | Pas encore en recrutement |
| Research Site | Kolkata | West Bengal | Pas encore en recrutement |
| Research Site | Lucknow | Uttar Pradesh | Pas encore en recrutement |
| Research Site | Mumbai | Maharashtra | Pas encore en recrutement |
| Research Site | Nagpur | Maharashtra | Pas encore en recrutement |
| Research Site | Pune | Maharashtra | Pas encore en recrutement |
| Research Site | Pune | Maharashtra | Pas encore en recrutement |
| Research Site | Thiruvananthapuram | Kerala | Pas encore en recrutement |
Malaysia
| Établissement | Ville | État ou région | Statut |
|---|---|---|---|
| Research Site | Batu Caves | Selangor | Retiré |
| Research Site | Kuala Lumpur | Wilayah Persekutuan Kuala Lump | Pas encore en recrutement |
| Research Site | Putrajaya | Pas encore en recrutement | |
| Research Site | Seremban | Negeri Sembilan | En recrutement |
| Research Site | Seri Manjung | Perak | Pas encore en recrutement |
Poland
| Établissement | Ville | État ou région | Statut |
|---|---|---|---|
| Research Site | Bialystok | Podlaskie Voivodeship | En recrutement |
| Research Site | Częstochowa | Silesian Voivodeship | Pas encore en recrutement |
| Research Site | Kielce | Świętokrzyskie Voivodeship | Pas encore en recrutement |
| Research Site | Krakow | Malopolska | Pas encore en recrutement |
| Research Site | Lodz | Łódź Voivodeship | En recrutement |
26 sites supplémentaires sont indiqués dans la fiche du registre.
Documents de l'étude
Aucun document n'est lié dans cette fiche du registre.
Évolution au fil du temps
- 25 août 2026
Site ajouté
5 sites added (76 total)
7176